AR222691A1 - Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina - Google Patents

Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina

Info

Publication number
AR222691A1
AR222691A1 AR280106A AR28010680A AR222691A1 AR 222691 A1 AR222691 A1 AR 222691A1 AR 280106 A AR280106 A AR 280106A AR 28010680 A AR28010680 A AR 28010680A AR 222691 A1 AR222691 A1 AR 222691A1
Authority
AR
Argentina
Prior art keywords
isopropylamine
hydroxy
procedure
preparation
pirimidine derivatives
Prior art date
Application number
AR280106A
Other languages
English (en)
Spanish (es)
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR222691(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Application granted granted Critical
Publication of AR222691A1 publication Critical patent/AR222691A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR280106A 1979-03-10 1980-02-27 Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina AR222691A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
AR222691A1 true AR222691A1 (es) 1981-06-15

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
AR280106A AR222691A1 (es) 1979-03-10 1980-02-27 Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina

Country Status (24)

Country Link
JP (1) JPS55122768A (US20020193084A1-20021219-M00002.png)
AR (1) AR222691A1 (US20020193084A1-20021219-M00002.png)
AU (1) AU533547B2 (US20020193084A1-20021219-M00002.png)
BE (1) BE881752A (US20020193084A1-20021219-M00002.png)
CA (1) CA1132561A (US20020193084A1-20021219-M00002.png)
CH (1) CH644368A5 (US20020193084A1-20021219-M00002.png)
DE (3) DE3050999C2 (US20020193084A1-20021219-M00002.png)
EG (1) EG14282A (US20020193084A1-20021219-M00002.png)
FI (1) FI66357C (US20020193084A1-20021219-M00002.png)
FR (2) FR2451370A1 (US20020193084A1-20021219-M00002.png)
GB (1) GB2045756B (US20020193084A1-20021219-M00002.png)
HK (1) HK55383A (US20020193084A1-20021219-M00002.png)
IE (1) IE49547B1 (US20020193084A1-20021219-M00002.png)
IN (1) IN153791B (US20020193084A1-20021219-M00002.png)
LU (1) LU82185A1 (US20020193084A1-20021219-M00002.png)
MX (1) MX6218E (US20020193084A1-20021219-M00002.png)
MY (1) MY8400200A (US20020193084A1-20021219-M00002.png)
NL (1) NL184833C (US20020193084A1-20021219-M00002.png)
NO (1) NO154054C (US20020193084A1-20021219-M00002.png)
NZ (1) NZ192927A (US20020193084A1-20021219-M00002.png)
OA (1) OA06484A (US20020193084A1-20021219-M00002.png)
PT (1) PT70882A (US20020193084A1-20021219-M00002.png)
SE (1) SE435180B (US20020193084A1-20021219-M00002.png)
SG (1) SG22683G (US20020193084A1-20021219-M00002.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
NZ192927A (en) 1981-07-13
FR2451370B1 (US20020193084A1-20021219-M00002.png) 1983-05-13
NL8001289A (nl) 1980-09-12
FI66357C (fi) 1984-10-10
AU533547B2 (en) 1983-12-01
MX6218E (es) 1984-12-21
NO800664L (no) 1980-09-11
DE3016752C2 (US20020193084A1-20021219-M00002.png) 1987-06-25
EG14282A (en) 1983-09-30
NO154054B (no) 1986-04-01
IE49547B1 (en) 1985-10-30
CH644368A5 (en) 1984-07-31
AU5624880A (en) 1980-09-18
DE3009071C2 (de) 1985-11-14
NL184833B (nl) 1989-06-16
CA1132561A (en) 1982-09-28
GB2045756A (en) 1980-11-05
NL184468B (nl) 1989-03-01
NL184833C (nl) 1989-11-16
HK55383A (en) 1983-11-25
NO154054C (no) 1986-07-09
LU82185A1 (fr) 1980-06-06
OA06484A (fr) 1981-07-31
JPS55122768A (en) 1980-09-20
GB2045756B (en) 1983-01-26
DE3016752A1 (de) 1980-12-04
IN153791B (US20020193084A1-20021219-M00002.png) 1984-08-18
FR2451191A1 (fr) 1980-10-10
FI66357B (fi) 1984-06-29
DE3050999A1 (US20020193084A1-20021219-M00002.png) 1985-08-14
SE8001812L (sv) 1980-09-11
MY8400200A (en) 1984-12-31
FR2451191B1 (US20020193084A1-20021219-M00002.png) 1983-04-29
BE881752A (fr) 1980-05-30
IE800477L (en) 1980-09-10
SE435180B (sv) 1984-09-10
FR2451370A1 (fr) 1980-10-10
JPS6126996B2 (US20020193084A1-20021219-M00002.png) 1986-06-23
FI800566A (fi) 1980-09-11
SG22683G (en) 1983-12-16
PT70882A (en) 1980-03-01
DE3050999C2 (de) 1986-08-14
DE3009071A1 (de) 1980-09-11

Similar Documents

Publication Publication Date Title
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES490536A0 (es) Procedimiento para la preparacion de derivados de la glici- namida
ES494635A0 (es) Procedimiento de preparacion de derivados de tiadiazol
ES492891A0 (es) Procedimiento para la preparacion de derivados triyodados deacido 5-amino- isoftalico
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
AR222691A1 (es) Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina
ES491142A0 (es) Procedimiento para la preparacion de derivados de fenileti- lamina
ES491154A0 (es) Procedimiento para la preparacion de derivados furanonicos
MX5215E (es) Procedimiento de preparacion de derivados de tienopiridina
ES493107A0 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
MX6221E (es) Procedimiento para la preparacion de derivados de homoserina
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
ES494286A0 (es) Procedimiento de preparacion de nuevos derivados 1,1,2-tri- fenilpropanos y -propenos
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
ES490999A0 (es) Procedimiento de preparacion de derivados hidroxilicos de isopropilamino-pirimidina
ES491004A0 (es) Procedimiento de preparacion de nuevos derivados halogenadosde isopropilamino-pirimidina
NO801724L (no) Fremgangsmaate for fremstilling av ergopeptin-derivater
AR223434A1 (es) Procedimiento para la preparacion de derivados de i-piperidino-ftalazina
ES497570A0 (es) Procedimiento de preparacion de derivados de ciclopropilani-linas
ES504338A0 (es) Procedimiento de preparacion de derivados difeniletericos
ES491738A0 (es) Procedimiento de preparacion de trihalogenuros organoestan- nicos
AR220367A1 (es) Procedimiento de preparacion de derivados de la 2-n-bencilidenamino-sulfamoil-benzamida
ES494222A0 (es) Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona